Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

Nusret Erdogan | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26022

Register Here

 

Ghazaleh Pouya | Pharmacology | Young Researcher Award

Published on by Invention Awards

Ms. Ghazaleh Pouya | Pharmacology Science | Young Researcher Award

Ms. Ghazaleh Pouya | Sechenov University | Russia

Ms. Ghazaleh Pouya is an aspiring pharmaceutical scientist and multidisciplinary researcher, currently pursuing a Master’s degree in Biology at Sechenov University with a focus on Innovative Medicines. With a Doctor of Pharmacy (Pharm.D.) degree from the same university, she integrates her clinical pharmaceutical knowledge with advanced research in transdermal drug delivery and AI-powered biomedical solutions. As a lab assistant and assistant researcher, she actively contributes to academic publications, interdisciplinary projects, and data analytics in pharma-biotech. Her curiosity and dedication to translational medicine, wound healing systems, and personalized therapeutics reflect in her dynamic academic and research involvement, positioning her as a promising young innovator at the intersection of pharmacy, biology, and artificial intelligence.

Profile

ORCID

Education

Ms. Ghazaleh earned her Pharm.D. from Sechenov University, completing a thesis on in-vitro modeling of aero-dispersed film-forming systems. Currently, she is enrolled in a Master’s program in Biology, focusing on Innovative Medicines, at the same institution. In parallel, she undertakes applied IT training at School-21, a program dedicated to programming, app development, and clinical data analysis in medicine. Her multidisciplinary training bridges biological sciences, medical informatics, and pharmaceutical technologies. Ms. Ghazaleh’s strong academic background provides her with a unique perspective in drug delivery development and biomedical computation, preparing her for impactful contributions to pharmaceutical innovation and AI-assisted healthcare systems.

Experience

Ms. Ghazaleh Pouya is a laboratory assistant and student researcher at Sechenov University, actively involved in both experimental design and data analysis across pharmaceutical and biological domains, where she develops tools for clinical and pharmaceutical data evaluation. She collaborates with the Department of Pharmaceutical Technology, Department of Biology (Innovative Drugs), and the PHARMA-PREMIUM Scientific Research Center, contributing to a range of wound treatment, drug delivery, and AI-modeling projects. This diverse experience strengthens her competence in translational science, combining wet lab experimentation with computational modeling, ensuring real-world applicability of research findings.

Research Interests

Ms. Ghazaleh’s research focuses on transdermal drug delivery systems, pharmaceutical nanocarriers, and AI-integrated biomedical analytics. She is also exploring in vitro skin models, pharmacogenomics, and quality-by-design (QbD) strategies in formulation development. Her innovative mindset drives her to investigate how machine learning can optimize personalized drug delivery mechanisms, especially for wound treatment and skin permeability. She works on enhancing the bioavailability and targeted release of active substances using nano-based platforms, contributing to the next generation of smart drug delivery systems. Ghazaleh’s vision blends biological sciences, digital health, and pharmaceutical technology for patient-centered therapeutic innovations.

Award

Ms. Ghazaleh Pouya is a strong candidate for the “Young Researcher Award” under the International Invention Awards 2025. Her multidisciplinary background, three completed co-authored publications, ongoing research in pharmaceutical aerosols, and AI-driven drug delivery platforms reflect her impactful contributions at an early stage of her career. Her experience across pharmaceutical formulation, lab analytics, and computational modeling positions her among the emerging leaders in pharm-biotech research. Her self-driven participation in interdepartmental and interdisciplinary collaborations exemplifies the qualities of a future research innovator. This award would not only recognize her current achievements but also catalyze her continued excellence in translational research.

Publications

Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation

Development of water vapor permeability determination methodology for spray film-forming systems

characterization and screening parameters of spray film-forming systems: a comprehensive study on dosage forms and quality indicators

Conclusion

Ms. Ghazaleh Pouya embodies the ideal profile of a rising biomedical innovator, integrating academic rigor, hands-on laboratory experience, and computational skills into a cohesive research journey. Her contributions to pharmaceutical sciences, particularly in film-forming drug systems and skin permeability, along with her novel integration of AI in drug delivery, showcase her potential to advance therapeutic design. With publications in reputable journals, active institutional collaborations, and an interdisciplinary mindset, she has already laid a strong foundation for a successful career in science and innovation. Recognition through the Young Researcher Award will further encourage her to expand her scientific impact and pursue future breakthroughs in personalized medicine and nanopharmaceuticals.